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119 Echocardiographic Correlates of Acute Heart Failure, Cardiogenic Shock, and
In-Hospital Mortality in Tako-Tsubo Cardiomyopathy
Rodolfo Citro, Fausto Rigo, Antonello D’Andrea, Quirino Ciampi, Guido Parodi,
Gennaro Provenza, Raffaele Piccolo, Marco Mirra, Concetta Zito, Roberta Giudice,
Marco Mariano Patella, Francesco Antonini-Canterin, Eduardo Bossone,
Federico Piscione, Jorge Salerno-Uriarte, on behalf of the Tako-Tsubo Italian
Network Investigators
Vini: Although tako-tsubo cardiomyopathy (TTC) is usually a reversible condition, adverse
cardiovascular outcomes during the acute phase can be associated with signiﬁcant morbidity
and mortality. Predictors of such outcomes have not yet been established.
Vidi: The aim of this study was to determine clinical and echocardiographic correlates of major
adverse events (composite of acute heart failure, cardiogenic shock, and in-hospital mortality).
After multivariate analysis, left ventricular ejection fraction, E/e’ ratio, reversible moderate to
severe mitral regurgitation and age 75 years were independent correlates of major adverse
events that occurred in 59 patients (25.9%).
Vici: This is a small study and additional external validation of these results is needed. However,
one can envision the use of these clinical and echocardiographic correlates in the future to
develop a risk prediction score to determine which patients with TTC require more aggressive
management during the acute phase.
130 EDITORIAL COMMENT Role of Echocardiography in Tako-Tsubo Cardiomyopathy:
Beyond Diagnosis?
John D. Horowitz, Thanh H. Nguyen
133 CMR-Based Differentiation of AL and ATTR Cardiac AmyloidosisJason N. Dungu, Oswaldo Valencia, Jennifer H. Pinney, Simon D. J. Gibbs,
Dorota Rowczenio, Janet A. Gilbertson, Helen J. Lachmann, Ashutosh Wechalekar,
Julian D. Gillmore, Carol J. Whelan, Philip N. Hawkins, Lisa J. Anderson
Vini: As cardiac magnetic resonance (CMR) techniques are continuing to improve, the nonin-
vasive detection of cardiac amyloidosis has increased. In particular, little is known about trans-
thyretin-related amyloidosis (ATTR), which does not have the typical subendocardial late
gadolinium enhancement (LGE) that is seen in light chain amyloid (AL) amyloidosis.
Vidi: LGE was more extensive in ATTR compared to AL amyloidosis, with the majority of patients
demonstrating transmural LGE and all patients having right ventricular LGE. Using these results,
a LGE scoring system was derived to differentiate these 2 subtypes with 87% sensitivity and 96%
speciﬁcity.
Vici: Precise diagnosis of cardiac amyloidosis is crucial given the role of chemotherapy in AL type
and with novel therapies for ATTR type currently in development. This study offers a remarkably
effective tool, which is likely to become a mainstay in clinical practice, for distinguishing these 2
subtypes of the disease.(continued on page A-8)
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A-8143 CMR Imaging With Rapid Visual T1 Assessment Predicts Mortality in Patients
Suspected of Cardiac Amyloidosis
James A. White, Han W. Kim, Dipan Shah, Nowell Fine, Ki-Young Kim,
David C. Wendell, Wael Al-Jaroudi, Michele Parker, Manesh Patel,
Femida Gwadry-Sridhar, Robert M. Judd, Raymond J. Kim
Vini: There are echocardiographic ﬁndings that may suggest cardiac amyloidosis (CA). However,
endomyocardial biopsy is usually needed to deﬁnitely make the diagnosis. Delayed enhance-
ment cardiac magnetic resonance (DE-CMR) is still evolving as a tool for the noninvasive diag-
nosis of CA.
Vidi: Here, the diagnostic and prognostic characteristics of DE-CMR with a rapid, visual T1-
assessment method for identiﬁcation of cardiac amyloidosis is reported. Multivariable analysis
showed diffuse global hyperenhancement (HE) to be the strongest predictor of death with the
accuracy of diffuse HE for the diagnosis of CA to be 84%. Therefore, visual T1-assessment
accurately identiﬁes patients with CA and those at risk of death.
Vici: This work offers a practical visual approach to interpreting DE-CMR that provides inde-
pendent diagnostic and prognostic information that can be easily adopted when considering the
diagnosis of CA. Additional correlation with other clinical and imaging correlates still needs
further study.
157 Native T1 Mapping in Transthyretin AmyloidosisMarianna Fontana, Sanjay M. Banypersad, Thomas A. Treibel, Viviana Maestrini,
Daniel M. Sado, Steven K. White, Silvia Pica, Silvia Castelletti, Stefan K. Piechnik,
Matthew D. Robson, Janet A. Gilbertson, Dorota Rowczenio, David F. Hutt,
Helen J. Lachmann, Ashutosh D. Wechalekar, Carol J. Whelan, Julian D. Gillmore,
Philip N. Hawkins, James C. Moon
Vini: Cardiac transthyretin-related amyloidosis (ATTR) amyloidosis is an under-diagnosed cause
of heart failure and no truly quantitative test exists to diagnose it. Recently, native myocardial T1
mapping has been shown in cardiac light chain amyloid (AL) to track the disease.
Vidi: The diagnostic role of native T1 mapping in ATTR amyloidosis was assessed compared with
ATTR mutation carriers, AL patients, healthy volunteers, and hypertrophic cardiomyopathy
patients. T1 was elevated in ATTR patients compared to HCM and normal subjects but the
elevation was lower than in AL patients. T1 tracked cardiac amyloid burden and was an early
disease marker.
Vici: Although this study lacks histological validation, it suggests that septal T1 mapping can be
used to distinguish different phenotypes of amyloidosis. The implications for this are tremen-
dous. Once T1 has been standardized across manufacturers, this technology can be utilized,
perhaps even with whole-heart T1 mapping, to diagnose and track disease progression in
response to treatment.
166 EDITORIAL COMMENT CMR and Amyloid Cardiomyopathy: Are We Getting Closer
to the Biology?
Raymond Y. Kwong, Michael Jerosch-Herold(continued on page A-9)
february 2014
volume 7, no. 2
A-9169 CT Angiography–Fluoroscopy Fusion Imaging for Percutaneous Transapical AccessChad Kliger, Vladimir Jelnin, Sonnit Sharma, Georgia Panagopoulos, Bryce N. Einhorn,
Robert Kumar, Francisco Cuesta, Leandro Maranan, Itzhak Kronzon, Bart Carelsen,
Howard Cohen, Gila Perk, Rob Van Den Boomen, Cherif Sahyoun, Carlos E. Ruiz
Vini: Structural heart disease interventions, including transapical access (TA), are commonly
obtained under ﬂuoroscopic guidance, and lack important spatial information.
Vidi: In this small proof-of-principle study of 20 patients utilizing computed tomography angi-
ography–ﬂuoroscopy fusion for TA, there were no coronary artery lacerations and the actual
puncture site was approximated near the intended or planned puncture site, despite cardiac
motion.
Vici: Additional work on whether the use of this hybrid imaging technology decreases proce-
dural complications is needed. Fusion imaging has the potential to improve procedural efﬁcacy
and safety, while reducing radiation exposure, contrast volume requirements, and procedural
duration. The future of cardiac imaging may include adoption of other such fusion technologies
into a variety of clinical settings.
178 PET/CT Imaging of Integrin avb3 Expression in Human Carotid AtherosclerosisAmbros J. Beer, Jaroslav Pelisek, Peter Heider, Antti Saraste, Christian Reeps,
Stephan Metz, Stefan Seidl, Horst Kessler, Hans-Jürgen Wester,
Hans Henning Eckstein, Markus Schwaiger
Vini: There has been a recent paradigm shift in imaging of atherosclerotic lesions from
anatomical characteristics only to anatomical as well as functional characteristics. The integrin
avb3 is expressed by macrophages and angiogenic endothelial cells in atherosclerosis and thus
is a potential marker of plaque inﬂammation and vulnerability.
Vidi: Tracer uptake in plaques of 10 patients prior to carotid endarterectomy was quantiﬁed and
correlated with immunohistochemistry. [18F]Galacto-RGD positron emission tomography (PET)/
computed tomography (CT) showed signiﬁcantly higher target/background-ratios in stenotic
compared to nonstenotic areas and target/background-ratios correlated signiﬁcantly with avb3-
expression.
Vici: By correlating [18F]Galacto-RGD PET/CT, a well-established radiotracer and imaging
modality, with plaque inﬂammation and vulnerability, this study demonstrates the ease of
incorporating functional assessment into previously established imaging protocols. This opens
the door for the use of functional imaging modalities as a novel “biomarker” in assessment and
management of cardiovascular risk.(continued on page A-10)
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A-10S T A T E - O F - T H E - A R T P A P E R188 Exercise Testing in Asymptomatic Severe Aortic StenosisJulien Magne, Patrizio Lancellotti, Luc A. PiérardI M A G I N G V I G N E T T E200 Manifestations of Cardiac Disease in Carotid Duplex Ultrasound ExaminationSurabhi Madhwal, Sandra Yesenko, Esther Soo Hyun Kim, Margaret Park,
Susan M. Begelman, Heather L. GornikL E T T E R S T O T H E E D I T O R204 3D OCT Versus FFR for Jailed Side-Branch Ostial StenosesJinyong Ha, Jung-Sun Kim, Gary S. Mintz, Byeong-Keuk Kim, Dong-Ho Shin,
Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong
205 ICE-Classiﬁcation of Interatrial Septum Anatomy in Patients With R/L ShuntGianluca Rigatelli, Fabio Dell’Avvocata, Dobrin Vassiliev, Ramesh Daggubati,
Ashesh Buch, Aravinda Nanjiundappa, Massimo Giordan, Laura Oliva, Dario Adami,
Paolo Cardaioli
206 Perﬂutren-Based Echocardiographic Contrast in Patients With Right-to-Left
Intracardiac Shunts
Ankur Kalra, Gautam R. Shroff, Darryl Erlien, David T. Gilbertson, Charles A. Herzog
207 LV Noncompaction in Ebstein’s Anomaly in Infants and OutcomesRicardo H. Pignatelli, Karen M. Texter, Susan W. Denﬁeld, Michelle A. Grenier,
Carolyn A. Altman, Nancy A. Ayres, Subash Chandra-Bose Reddy(continued on page A-11)
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A-11E D I T O R ’ S P A G E210 CMR of Amyloidosis: Looking Between the SheetsChristopher M. Kramer, Jagat NarulaI M A G I N G C O U N C I L C H A I R M A N ’ S P A G E212 Demystifying Imaging Laboratory AccreditationGeoffrey A. Rose, Neil J. WeissmanO N T H E C O V E RLV Noncompaction in Congenital Heart Disease: Correlation of Pathologic
Findings and 2D Echo in Ebstein’s AnomalyAutopsy specimen of a neonate with Ebstein’s anomaly with right atrium opened to
show the small right ventricle (left panel), plastered septal leaﬂet, and the dense
trabeculations with recesses in the left ventricle (LV) (middle panel). The right panel
shows an echocardiogram in the apical 4-chamber view showing the trabeculations
in the LV. Please see Pignatelli et al. (page 207) for the related article.
